Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients

被引:333
作者
Calarota, S
Bratt, G
Nordlund, S
Hinkula, J
Leandersson, AC
Sandström, E
Wahren, B [1 ]
机构
[1] Karolinska Inst, Swedish Inst Infect Dis Control, Ctr Microbiol & Tumor Biol, S-10521 Stockholm, Sweden
[2] South Hosp, Dept Dermatovenereol, Stockholm, Sweden
关键词
D O I
10.1016/S0140-6736(97)09440-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background DNA vaccination is known to generate immune responses against HIV-1 in animal models. We aimed to assess the efficacy of DNA vaccination in induction of immune responses in HIV-1-infected human beings. Methods Nine symptom-free HIV-1-infected patients were immunised with DNA constructs encoding the nef, rev, or tat regulatory genes of HIV-1. The patients were selected for having no or low antibody reactivities to these antigens. HIV-1-specific cytotoxic T-lymphocytes (CTLs), precursor frequencies, and antigen-specific proliferative responses were measured before, during, and after three immunisations over 6 months. Findings Cellular immune reactivities against the HIV-1 regulatory proteins were absent or low before DNA immunisation. DNA vaccination induced detectable memory cells in all patients and specific cytotoxicity in eight patients. CTLs were MHC-class-I restricted and mainly of CD8+ origin. In three patients the cellular activity was transient, decreasing after an initial response. Interpretation DNA immunisation with HIV-1 genes can induce specific cellular responses in human beings with no apparent side-effects. It is theoretically possible that HIV-1-specific cytotoxic responses to regulatory proteins could lead to infected cells being eliminated before they have released new viral particles. However, it is possible that the patients we selected responded less than would nonselected or non-infected individuals. The small number of patients presented here does not allow generalisation of our findings.
引用
收藏
页码:1320 / 1325
页数:6
相关论文
共 38 条
  • [1] Asakura Y, 1996, AM J HEMATOL, V53, P116, DOI 10.1002/(SICI)1096-8652(199610)53:2&lt
  • [2] 116::AID-AJH9&gt
  • [3] 3.0.CO
  • [4] 2-2
  • [5] BOYER JD, 1997, NAT MED, V3, P525
  • [6] QUANTITATIVE-ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SPECIFIC CYTOTOXIC LYMPHOCYTE-T (CTL) RESPONSE AT DIFFERENT STAGES OF HIV-1 INFECTION - DIFFERENTIAL CTL RESPONSES TO HIV-1 AND EPSTEIN-BARR-VIRUS IN LATE DISEASE
    CARMICHAEL, A
    JIN, X
    SISSONS, P
    BORYSIEWICZ, L
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) : 249 - 256
  • [7] CEASE KB, 1994, ANNU REV IMMUNOL, V12, P923, DOI 10.1146/annurev.iy.12.040194.004423
  • [8] MECHANISM OF ACTION OF REGULATORY PROTEINS ENCODED BY COMPLEX RETROVIRUSES
    CULLEN, BR
    [J]. MICROBIOLOGICAL REVIEWS, 1992, 56 (03) : 375 - 394
  • [9] Human immunodeficiency virus type-1 (HIV-1)- and Epstein-Barr virus specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1-infected persons
    Geretti, AM
    Dings, MEM
    vanEls, CACM
    vanBaalen, CA
    Wijnholds, FJ
    Borleffs, JCC
    Osterhaus, ADME
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (01) : 34 - 45
  • [10] HIGH-FREQUENCY OF MEMORY AND EFFECTOR GAG SPECIFIC CYTOTOXIC LYMPHOCYTES-T IN HIV SEROPOSITIVE INDIVIDUALS
    GOTCH, FM
    NIXON, DF
    ALP, N
    MCMICHAEL, AJ
    BORYSIEWICZ, LK
    [J]. INTERNATIONAL IMMUNOLOGY, 1990, 2 (08) : 707 - 712